2 weeks Ago By Defense World Staff
Guardian Pharmacy Services, Inc. ( NYSE:GRDN – Get Free Report ) Director Thomas J. Salentine, Jr.
bought 35,714 shares of the company’s stock in a transaction on Friday, September 27th. The stock was bought at an average cost of $14.00 per share, with a total value of $499,996.
00. Following the completion of the acquisition, the director now owns 35,714 shares of the company’s stock, valued at approximately $499,996. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website .
Guardian Pharmacy Services Stock Performance Shares of GRDN traded up $0.20 during mid-day trading on Tuesday, reaching $17.00.
The company’s stock had a trading volume of 367,888 shares, compared to its average volume of 430,236. Guardian Pharmacy Services, Inc. has a 1 year low of $14.
16 and a 1 year high of $20.10. Guardian Pharmacy Services Company Profile ( Get Free Report ) See Also Five stocks we like better than Guardian Pharmacy Services Consumer Discretionary Stocks Explained Why Lennar Stock Could Be the Best Play in the Housing Market What is the S&P/TSX Index? 2 Energy Stocks Fueling the AI Datacenter Boom The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech? Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.
com's FREE daily email newsletter ..
